Dr. Aaron R. Alizadeh, MD
- Medicare services, 2024
- 689
- Medicare patients, 2024
- 250
- Part D claims, 2024
- 1,511
- Publications
- 1
- Clinical trials
- 5
- Practice address
- 401 Castle Creek Rd, Aspen, CO 81611
- Practice phone
- Call (970) 544-1261
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Alizadeh's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Aaron R. Alizadeh is a hematologist and oncologist in Aspen, Colorado
Dr. Alizadeh practices at Aspen Valley Health in Aspen, Colorado, part of Aspen Valley Health.
Dr. Alizadeh's NPI, 1063412567, was assigned on July 26, 2005. Dr. Alizadeh graduated from Wayne State University School of Medicine in 1997. Dr. Alizadeh holds Georgia license 046027.
- NPI
- 1063412567NPI Registry (opens in a new tab)
- Medicare PAC ID
- 1951290154
- NPI enumeration date
- July 26, 2005
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (970) 544-1261
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 55
- Medical school graduation
- 1997
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Aaron R. Alizadeh practices at Aspen Valley Health in Aspen, Colorado
Dr. Alizadeh's primary practice is Aspen Valley Health, at 401 Castle Creek Rd, Aspen, CO 81611 in Pitkin County. The practice phone is (970) 544-1261.
- Aspen Valley Health401 Castle Creek Rd, Aspen, CO 81611 · Pitkin CountyPhone(970) 544-1261
Source: Dmand AI Affiliation Data
Dr. Aaron R. Alizadeh is affiliated with 6 sites of care and 4 medical groups
Dr. Alizadeh's primary practice is Aspen Valley Health in Aspen, Colorado, part of Aspen Valley Health. Dr. Alizadeh is also affiliated with Northside Hospital Atlanta. The medical group on file is Aspen Valley Health. Dmand AI also links Dr. Alizadeh to 3 more hospitals, 3 medical groups and 1 group practice or clinic, each named with a free account. Dr. Alizadeh's employer is on file too: a hospital.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Aaron R. Alizadeh's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alizadeh practices, 6 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Aspen Valley Health | Available with a free account |
| +5 more sites and 3 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Aspen Valley Health and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Aaron R. Alizadeh is one of 179 hematologists and oncologists in Colorado
Hematology and oncology is Dr. Alizadeh's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Alizadeh is licensed in Georgia.
Specialties and state licenses
- Hematology and oncology, GeorgiaPrimary
Hematologists and oncologists near Dr. Alizadeh
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Aaron R. Alizadeh billed Medicare for 689 services in 2024
CMS data shows 689 Medicare services from Dr. Alizadeh across 9 procedure codes in 2024, for 250 Medicare patients. Medicare paid $44,417 for them.
Dr. Alizadeh's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 6262024: 6758%
- Other services
- 2023: 02024: 14
Where Dr. Alizadeh's Medicare services took place, 2024
- In an office64493%
- In a facility457%
Dr. Alizadeh compared with the Colorado median for hematologists and oncologists, 2024
- Dr. Alizadeh
- Colorado median
- Medicare services
- 689vs 62410% above
- Medicare patients
- 250vs 242Close to median
- Part D claims
- 1,166vs 5032.3 times
Medians across 181 hematologists and oncologists in Colorado with Dmand AI profiles that report each measure.
Dr. Alizadeh's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Alizadeh?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Alizadeh and other hematologists and oncologists in Colorado.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Aaron R. Alizadeh treated 250 Medicare patients in 2024, average age 74
CMS counts 250 Medicare patients who saw Dr. Alizadeh in 2024. The largest group is 65 to 74, with 109 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Alizadeh's median patient age at 72, with 48% women.
Dr. Alizadeh's Medicare patients by age, 2024
Dr. Alizadeh's Medicare patients by sex, 2024
- Women14859%
- Men10241%
Chronic conditions among Dr. Alizadeh's Medicare patients, 2024
- High blood pressure75%
- High cholesterol73%
- Arthritis42%
- Cancer40%
- Diabetes32%
- Chronic kidney disease30%
- Ischemic heart disease20%
- Osteoporosis20%
Share of Medicare patients with each condition. A patient can have several.
Dr. Alizadeh's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 72
Patient panel by sex, all payers
- Women48%
- Men51%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Aaron R. Alizadeh wrote 1,511 Medicare Part D claims in 2024
In 2024, Dr. Alizadeh wrote 1,511 Medicare Part D claims for 261 patients. 72% of them were for generic drugs. CMS names the drug for 1,166 of them, across 44 drugs with 11 or more claims each, at $3,314,034 in total drug cost. In 2023, CMS named 1,018 claims across 40 drugs.
Dr. Alizadeh's Part D claims by kind of drug, 2024
- Generic1,081 claims72%
- Brand-name430 claims28%
Dr. Alizadeh's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Alizadeh's Part D claims, 2024
- Opioids11%164 of 1,511 claims
- Antibiotics1%17 of 1,511 claims
- Antipsychotics, patients 65 and over1%22 of 1,511 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,0182024: 1,16615%
Drugs named by CMS: 44 in 2024, 40 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Aaron R. Alizadeh scored 71 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 71 out of 100 for Dr. Alizadeh for performance year 2024, reported as part of a group. Dr. Alizadeh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alizadeh as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Alizadeh's MIPS scores, performance year 2024
- 71of 100Final score
- 69.2of 100Quality
- 40of 100Improvement Activities
- 51of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Aaron R. Alizadeh has 1 publication on record
Dmand AI links 1 paper to Dr. Alizadeh in 2019. Dr. Alizadeh's most frequent co-authors are Charles Lance Cowey, MD, Omid Hamid, MD and Lowell L. Hart, MD.
Dr. Alizadeh's most frequent co-authors
Recent publications by Dr. Alizadeh
See who Dr. Alizadeh researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Alizadeh works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Aaron R. Alizadeh has worked on 5 clinical trials
Dmand AI links Dr. Alizadeh to 5 clinical trials, 2 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Melanoma and Nevi and Melanomas. National Cancer Institute (NCI) sponsors the most, 3.
Clinical trials with Dr. Alizadeh by phase
- NonePhase 1: no trials
- 1Phase 1/2: 1 trial
- 1Phase 2: 1 trial
- 1Phase 2/3: 1 trial
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Conditions in Dr. Alizadeh's trials
- Melanoma
- Nevi and Melanomas
Investigators on the most trials with Dr. Alizadeh
- Robert Martin Conry, MD4 shared trials
- Sunandana Chandra, MD3 shared trials
- Srinivas Sankarnaga Devarakonda, MD3 shared trials
Recent clinical trials with Dr. Alizadeh
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma (opens in a new tab)
Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery (opens in a new tab)
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Aaron R. Alizadeh received $1,979 in industry payments from 2016 to 2025
CMS Open Payments shows 54 general payments to Dr. Alizadeh from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Bristol-Myers Squibb Company paid the most, $207.
General payments to Dr. Alizadeh by program year, 2016 to 2025
General payments to Dr. Alizadeh by kind, 2016 to 2025
- Food and beverage$1,80391%
- Education$1769%
Companies that paid Dr. Alizadeh the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Aaron R. Alizadeh graduated from Wayne State University School of Medicine
Dr. Alizadeh graduated from Wayne State University School of Medicine in 1997.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Aaron R. Alizadeh's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Aaron R. Alizadeh
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Aaron R. Alizadeh's NPI number?
Dr. Aaron R. Alizadeh's NPI number is 1063412567. It was assigned on July 26, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Aaron R. Alizadeh?
Dr. Aaron R. Alizadeh is a hematologist and oncologist in Aspen, Colorado. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Aaron R. Alizadeh practice?
Dr. Alizadeh practices at 401 Castle Creek Rd, Aspen, CO 81611. Dr. Alizadeh's primary practice is Aspen Valley Health in Aspen, Colorado, part of Aspen Valley Health. Dmand AI also links Dr. Alizadeh to 3 hospitals, 3 medical groups and 1 group practice or clinic.
What is Dr. Aaron R. Alizadeh's office phone number?
The practice phone on file for Dr. Alizadeh is (970) 544-1261.
What is Dr. Aaron R. Alizadeh's medical license number?
Dr. Alizadeh holds Georgia license 046027.
Which hospitals is Dr. Aaron R. Alizadeh affiliated with?
Dr. Alizadeh practices at Aspen Valley Health in Aspen, Colorado. Dr. Alizadeh is also affiliated with Northside Hospital Atlanta. Dmand AI links Dr. Alizadeh to 3 more hospitals.
What medical group is Dr. Aaron R. Alizadeh part of?
Dr. Alizadeh is linked to Aspen Valley Health. Dmand AI links Dr. Alizadeh to 3 more medical groups.
Does Dr. Aaron R. Alizadeh accept Medicare?
Yes. CMS data shows Dr. Alizadeh billed Medicare for 689 services in 2024, and Dr. Alizadeh accepts Medicare assignment.
Does Dr. Aaron R. Alizadeh offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Alizadeh as offering telehealth services.
What is Dr. Aaron R. Alizadeh's MIPS score?
Dr. Alizadeh's MIPS final score for performance year 2024 is 71 out of 100, reported as part of a group.
Show 8 more questionsShow fewer questions
How many Medicare patients does Dr. Aaron R. Alizadeh see?
CMS counts 250 Medicare patients who saw Dr. Alizadeh in 2024, with an average age of 74.
What services does Dr. Aaron R. Alizadeh bill to Medicare?
In 2024, Dr. Alizadeh's most billed Medicare services were office visit, established patient (99213), office visit, established patient (99214) and office visit, established patient (99215).
Where did Dr. Aaron R. Alizadeh go to medical school?
Dr. Alizadeh graduated from Wayne State University School of Medicine in 1997.
What drugs does Dr. Aaron R. Alizadeh prescribe most?
In 2024 Medicare Part D data, Dr. Alizadeh's most prescribed drugs by claims were Anastrozole, Eliquis and Ondansetron HCl.
Has Dr. Aaron R. Alizadeh received payments from drug or device companies?
CMS Open Payments shows $1,979 in general payments to Dr. Alizadeh from 29 companies from 2016 to 2025. The largest total came from Bristol-Myers Squibb Company.
How long has Dr. Aaron R. Alizadeh been practicing?
Dr. Alizadeh graduated from medical school in 1997, 29 years ago.
Does Dr. Aaron R. Alizadeh do research?
Dmand AI links 1 publication to Dr. Alizadeh. Dr. Alizadeh has worked on 5 clinical trials.
Who does Dr. Aaron R. Alizadeh publish with?
Dr. Alizadeh's most frequent co-authors are Charles Lance Cowey, MD (1 shared paper), Omid Hamid, MD (1 shared paper) and Lowell L. Hart, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in Colorado by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card